Annovis Bio Inc
(ANVS)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2019 | 03-2019 | 12-2018 | |
| Assets | |||
| Current Assets | |||
| Cash & Cash Equivalents | 0 | 0 | 35 |
| Other current assets | 0 | 0 | 16 |
| TOTAL | $0 | $0 | $51 |
| Non-Current Assets | |||
| TOTAL | $N/A | $N/A | $N/A |
| Total Assets | $0 | $0 | $51 |
| Liabilities | |||
| Current Liabilities | |||
| Accounts payable and accrued liabilities | 0 | 0 | 68 |
| Accrued Expenses | 0 | 0 | 500 |
| TOTAL | $0 | $0 | $568 |
| Non-Current Liabilities | |||
| Other Non-Current Liabilities | 0 | 0 | 7,077 |
| TOTAL | $N/A | $N/A | $7,077 |
| Total Liabilities | $0 | $0 | $7,645 |
| Shareholders' Equity | |||
| Retained earnings | 0 | 0 | -7,786 |
| TOTAL | $0 | $0 | $-7,594 |
| Total Liabilities And Equity | $0 | $0 | $51 |